Heart Rhythm

Hearts should have normal rhythm to their beats, but when these beats are out of synch, it causes inefficient pumping of blood. Irregular heart arrhythmias occur when the electrical signals that coordinate the heart's beats do not work properly. This can cause beats that are too fast (tachycardia), or too slow (bradycardia). Tachycardias include atrial fibrillation (AFib), supraventricular tachycardia, ventricular fibrillation, and ventricular tachycardia (VT). Bradycardias include sick sinus syndrome and conduction block. Electrophysiology arrhythmia treatments include medications, life style changes, and the EP lab interventions of catheter ablation, and implantable pacemakers or defibrillators.

2 out of 5 AFib patients develop heart failure later in life
Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat.
FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy
The new gene therapy candidate is now one step closer to being approved by the FDA.
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
The anticoagulant was originally developed for patients with end-stage renal disease and atrial fibrillation.
Biosense Webster takes key step toward FDA approval for Varipulse PFA system
The company already received CE mark approval for its new PFA offering and hopes it will soon be approved for sale in the United States.
Cardiologists are first in world to remove unstable Watchman devices with FDA-cleared retrieval system
A team of specialists in Houston made history, using the new-look device to treat three patients over the age of 80. The group shared its experience in JACC: Clinical Electrophysiology.

Heart rhythm specialists awarded $3M to develop new AFib therapy

“AFib remains a serious arrhythmia, and additional treatment options are needed,” one cardiologist said.

September 20, 2021

Medtronic, Mpirik join forces to address disparities in care for patients at risk of sudden cardiac arrest

Vizient is also working closely with the two companies to boost patient care.

September 14, 2021

Healthy sleep patterns lower risk of AFib, bradyarrhythmia

Researchers tracked data from the UK Biobank study, sharing their analysis in the Journal of the American College of Cardiology.

September 14, 2021

Risk score predicts new‐onset HF among AFib patients in the ED

The study's authors hope their work can help high-risk patients receive the care they need.

September 14, 2021

How delayed peridevice leak after LAAC affects patient outcomes

Delayed PDL was identified in more than 10% of patients undergoing the procedure.

September 13, 2021

AFib patients face comparable dementia risk with DOACs and warfarin

Researchers tracked data from 25,948 adults over the age of 71.

September 13, 2021

People living with HIV face a heightened risk of sudden cardiac death

The risk was especially high in patients with high viral loads of HIV.

September 8, 2021

Electrocardiograms analyzed by AI can offer information about mortality risk.

Monitoring high-risk patients for AFib fails to reduce stroke risk

"These findings might imply that not all AFib is worth screening for, and not all screen-detected AFib merits anticoagulation," researchers wrote.

September 3, 2021

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Heart Rhythm

2 out of 5 AFib patients develop heart failure later in life

FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy

FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices

Biosense Webster takes key step toward FDA approval for Varipulse PFA system

Cardiologists are first in world to remove unstable Watchman devices with FDA-cleared retrieval system

Around the web